Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate effects on neural basis of anxiety
NCT02021214Phase 1Completed
- Sponsor
- University of California, San Diego
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylphenidate in post-traumatic stress disorder (PTSD) and anxiety disorders, sponsored by University of California, San Diego. Primary endpoint: Changes in blood oxygenation level-dependent BOLD signal responses at 6 hours. Started Mar 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
post-traumatic stress disorder (PTSD)anxiety disorders
Beyond the preview
Go deeper on NCT02021214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02021214.